Trials / Recruiting
RecruitingNCT06601569
Predictors of Range of Motion and Balance Abnormalities in Children Diagnosed with Cerebral Palsy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Months – 5 Years
- Healthy volunteers
- Not accepted
Summary
1. To better understand the factors that contribute to ROM abnormalities in children diagnosed with CP. 2. To describe the distribution of primary (muscle tone and postural stability)and secondary impairments (ROM and functional muscle strength) across the gross motor spectrum measured by GMFCS scores. 3. To evaluate the effects of primary and secondary impairments on gross functional outcome in children with spastic CP. 4. To find any possible correlation between clinical variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | balance and range of motion | * Spinal alignment and range of motion measure scale (SAROMM): is a measure of spinal alignment and range of motion using standard physical therapy techniques scored on a 5-point ordinal score of 0 (normal alignment and range with active correction) to4 ("severe" fixed deformity) (Bartlett ey al., 2005) * Modified Ashworth scale (MAS): is a measure of muscle motion and scoring the perceived resistance to movement on a scale of 1 (no increase in tone) to 5 (rigid in flexion or extension) (Clopton et al., 2005). * Early clinical assessment of balance (ECAB) scale: Is a 13-item test that estimates postural stability for children with CP across all levels of functional ability (Jeffries etal., 2016). * Functional strength assessment scale: Therapists completed a functional strength assessment (FSA) to obtain an estimate of strength for major muscle groups including the neck and trunk flexors and extensors, and hip extensors, knee extensors, and shoulder flexors bilaterally. |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2025-01-01
- Completion
- 2025-02-01
- First posted
- 2024-09-19
- Last updated
- 2024-10-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06601569. Inclusion in this directory is not an endorsement.